Pyxis Oncology, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Pyxis Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q2 2024.
- Pyxis Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.87M, a 21.7% decline year-over-year.
- Pyxis Oncology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $15.6M, a 14.1% decline year-over-year.
- Pyxis Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $16.9M, a 7.5% increase from 2022.
- Pyxis Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $15.8M, a 147% increase from 2021.
- Pyxis Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $6.37M, a 35300% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)